Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Update

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 27,000 shares, a drop of 44.8% from the February 28th total of 48,900 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ? days.

Laboratorios Farmaceuticos Rovi Price Performance

Shares of LABFF stock remained flat at C$65.86 during trading hours on Friday. Laboratorios Farmaceuticos Rovi has a 12 month low of C$65.86 and a 12 month high of C$65.86. The firm has a 50-day simple moving average of C$65.86 and a two-hundred day simple moving average of C$75.49.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.